BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Shahi PK, Wang X, Xie R, Zhao Y, Wu M, Roge S, Pattnaik BR, Gong S. In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles. J Control Release 2021;336:296-309. [PMID: 34174352 DOI: 10.1016/j.jconrel.2021.06.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hakim A, Guido B, Narsineni L, Chen DW, Foldvari M. Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems. Adv Drug Deliv Rev 2023;:114781. [PMID: 36940751 DOI: 10.1016/j.addr.2023.114781] [Reference Citation Analysis]
2 Sobhanan J, Anas A, Biju V. Nanomaterials for Fluorescence and Multimodal Bioimaging. Chem Rec 2023;23:e202200253. [PMID: 36789795 DOI: 10.1002/tcr.202200253] [Reference Citation Analysis]
3 Du W, Du S, Dong X, Bai H, Jiang J, Hao S, Yang F, Xiao Q, Zhang B, Ge J, Gao L, Li L, Yao SQ, Huang W. Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy. Biomaterials 2023;294:122000. [PMID: 36640541 DOI: 10.1016/j.biomaterials.2023.122000] [Reference Citation Analysis]
4 Zhu M, Wang X, Xie R, Wang Y, Xu X, Burger J, Gong S. Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles. ACS Appl Mater Interfaces 2023;15:10464-76. [PMID: 36800641 DOI: 10.1021/acsami.2c21683] [Reference Citation Analysis]
5 Wang Y, Wang X, Xie R, Burger JC, Tong Y, Gong S. Overcoming the Blood-Brain Barrier for Gene Therapy via Systemic Administration of GSH-Responsive Silica Nanocapsules. Adv Mater 2023;35:e2208018. [PMID: 36445243 DOI: 10.1002/adma.202208018] [Reference Citation Analysis]
6 Metzger JM, Wang Y, Neuman SS, Snow KJ, Murray SA, Lutz CM, Bondarenko V, Felton J, Gimse K, Xie R, Li D, Zhao Y, Flowers MT, Simmons HA, Roy S, Saha K, Levine JE, Emborg ME, Gong S. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins. Biomaterials 2023;293:121959. [PMID: 36527789 DOI: 10.1016/j.biomaterials.2022.121959] [Reference Citation Analysis]
7 Li J, Jian X, Wang Y, Zhong Z, Fu X, Deng G, Li Z. Fabrication of poly methylacrylate acid hybrid silica core‐shell microspheres with redox responsive biodegradability for drug delivery. J of Applied Polymer Sci 2023. [DOI: 10.1002/app.53630] [Reference Citation Analysis]
8 Husted S, Minutello F, Pinna A, Tougaard SL, Møs P, Kopittke PM. What is missing to advance foliar fertilization using nanotechnology? Trends Plant Sci 2023;28:90-105. [PMID: 36153275 DOI: 10.1016/j.tplants.2022.08.017] [Reference Citation Analysis]
9 Mazzotta E, De Santo M, Lombardo D, Leggio A, Pasqua L. Mesoporous silicas in materials engineering: Nanodevices for bionanotechnologies. Materials Today Bio 2022;17:100472. [DOI: 10.1016/j.mtbio.2022.100472] [Reference Citation Analysis]
10 Huang K, Zapata D, Tang Y, Teng Y, Li Y. In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications. Biomaterials 2022;291:121876. [PMID: 36334354 DOI: 10.1016/j.biomaterials.2022.121876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Foley RA, Sims RA, Duggan EC, Olmedo JK, Ma R, Jonas SJ. Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation. Front Bioeng Biotechnol 2022;10:973326. [DOI: 10.3389/fbioe.2022.973326] [Reference Citation Analysis]
12 Fang T, Cao X, Ibnat M, Chen G. Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing. J Nanobiotechnology 2022;20:354. [PMID: 35918694 DOI: 10.1186/s12951-022-01570-y] [Reference Citation Analysis]
13 Kabra M, Shahi PK, Wang Y, Sinha D, Spillane A, Newby GA, Saxena S, Abdeen AA, Edwards KL, Theisen CO, Gamm DM, Liu DR, Gong S, Saha K, Pattnaik BR. Nanoparticle mediated CRISPR base editing rescues Kir7.1 function relevant to ocular channelopathy.. [DOI: 10.1101/2022.07.12.499808] [Reference Citation Analysis]
14 Yang W, Yan J, Zhuang P, Ding T, Chen Y, Zhang Y, Zhang H, Cui W. Progress of delivery methods for CRISPR-Cas9. Expert Opin Drug Deliv 2022. [PMID: 35818792 DOI: 10.1080/17425247.2022.2100342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rahimi H, Zaboli KA, Thekkiniath J, Mousavi SH, Johari B, Hashemi MR, Nosrati H, Goldschneider D, Bernet A, Danafar H, Kaboli S. BSA-PEI Nanoparticle Mediated Efficient Delivery of CRISPR/Cas9 into MDA-MB-231 Cells. Mol Biotechnol 2022. [PMID: 35670994 DOI: 10.1007/s12033-022-00514-z] [Reference Citation Analysis]
16 Cordeiro R, Carvalho A, Durães L, Faneca H. Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor. Int J Mol Sci 2022;23:6243. [PMID: 35682920 DOI: 10.3390/ijms23116243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 2022. [PMID: 35642539 DOI: 10.1039/d1cs00659b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
18 Xie R, Wang X, Wang Y, Ye M, Zhao Y, Yandell BS, Gong S. pH-Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA. Adv Mater 2022;34:e2110618. [PMID: 35119139 DOI: 10.1002/adma.202110618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Burdușel A, Gherasim O, Andronescu E, Grumezescu AM, Ficai A. Inorganic Nanoparticles in Bone Healing Applications. Pharmaceutics 2022;14:770. [DOI: 10.3390/pharmaceutics14040770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Shin H, Kim J. Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy. Chem Commun (Camb) 2022. [PMID: 35040444 DOI: 10.1039/d1cc05999h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 He Y, Gu Z. Preparation and Evaluation of Reduction-Controlled Hierarchical Unpacking Terplexes for Gene Delivery. Biomaterial Engineering 2022. [DOI: 10.1007/978-981-33-6198-0_19-1] [Reference Citation Analysis]
22 He Y, Gu Z. Preparation and Evaluation of Reduction-Controlled Hierarchical Unpacking Terplexes for Gene Delivery. Biomaterial Engineering 2022. [DOI: 10.1007/978-981-16-5419-0_19] [Reference Citation Analysis]
23 Tang N, Ning Q, Wang Z, Tao Y, Zhao X, Tang S. Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches. Colloids Surf B Biointerfaces 2021;210:112257. [PMID: 34894597 DOI: 10.1016/j.colsurfb.2021.112257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Naeem M, Hoque MZ, Ovais M, Basheer C, Ahmad I. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing. Int J Mol Sci 2021;22:11300. [PMID: 34681959 DOI: 10.3390/ijms222011300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]